Home › Liver Diseases › Florida › Miami
Liver Diseases clinical trials in Miami, FL
4 studies for Liver Diseases are looking for participants at sites in and around Miami (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
RecruitingPhase 2
- Evolution Clinical Trials, Miami
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
RecruitingPhase 3
- 89bio Clinical Study Site, Miami
- 89bio Clinical Study Site, Miami
- 89bio Clinical Study Site, Miami
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
RecruitingPhase 3
- 89bio Clinical Study Site, Miami
Veteran-Centered Care for Advanced Liver Disease (Vet-CALD)
Recruiting
- Miami VA Healthcare System, Miami, FL, Miami
About Liver Diseases
Get the facts about liver diseases, such as hepatitis, cancer, and cirrhosis. Know your risk and what you can do to prevent liver problems.
More about Liver Diseases on MedlinePlus
Liver Diseases trials in other cities
- Houston, TX10 studies
- Chicago, IL10 studies
- Los Angeles, CA8 studies
- Atlanta, GA8 studies
- Washington, DC8 studies
- New York City, NY7 studies
- San Antonio, TX6 studies
- Richmond, VA6 studies
- Philadelphia, PA6 studies
- Ann Arbor, MI5 studies
- Durham, NC5 studies
- Aurora, CO5 studies
Other studies in Miami
- Breast Cancer42 studies
- Cancer (all types)36 studies
- Non-Small Cell Lung Cancer31 studies
- Prostate Cancer28 studies
- Obesity27 studies
- Acute Myeloid Leukemia24 studies
- Overweight23 studies
- Ovarian Cancer23 studies
- Metastatic Cancer23 studies
- Ulcerative Colitis22 studies
- Alzheimer's Disease21 studies
- Multiple Myeloma21 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.